Blood test detects more than 20 cancer types
A blood test being developed by Grail was able to detect more than 20 cancer types, including gastric and esophageal cancer, in... Read More
Better Short-Term Results With LADG in Stomach Cancer
A study found that patients who undergo minimally invasive laparoscopic gastrectomy are better able to tolerate chemotherapy for gastric cancer than are... Read More
Antibiotic use before cancer treatment cuts survival time study
Taking antibiotics in the month prior to starting immunotherapy for cancer can lessen the chance of survival, an important finding given the... Read More
Survival Benefit of Palliative Gastrectomy Followed by Chemotherapy for Stage IV Gastric Signet Ring Cell Carcinoma – copy
A study found a high rate of H. Pylori in patients undergoing sleeve gastrectomy for weight loss. That suggests there’s value in... Read More
ESMO Clinical Practice Guidelines for Surveillance of Hereditary Gastrointestinal Cancers
The European Society for Clinical Oncology (ESMO) issued new recommendations for screening patients who may face a high risk of gastrointestinal cancer.... Read More
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability as a Biomarker in Gastric Cancer
A new analysis shows that patients with gastric cancer that’s characterized and treated as microsatellite instability high (MSI-high) have favorable five-year survival... Read More
PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2
Expression of the coding RNA PCAT-1 is associated with cisplatin resistance in gastric cancer, and suppressing PCAT-1 can re-sensitize cancer cells to... Read More
Survival Benefit of Palliative Gastrectomy Followed by Chemotherapy for Stage IV Gastric Signet Ring Cell Carcinoma
Gastrectomy followed by chemotherapy can be more effective than chemo alone in gastric cancer patients with signet ring cell carcinoma, according to... Read More
Long noncoding RNA SNHG16 silencing inhibits the aggressiveness of gastric cancer via upregulation of microRNA-628-3p and consequent decrease of NRP1
Scientists in China discovered that low expression of a particular MicroRNA called miR-628 is associated with lymph-node metastasis and poor prognosis in... Read More
Checkpoint Inhibitor Checks in as Treatment for Advanced Gastric Cancers
Despite mixed results in clinical trials, Keytruda is producing promising survival results in some gastric cancer patients and has promise in combination... Read More
